Differential Diagnosis for Dry Cough with Normal Respiratory Findings
Most Likely Diagnoses
For a patient with dry cough and normal respiratory examination, the three most common causes are upper airway cough syndrome (UACS), asthma, and gastroesophageal reflux disease (GERD), in descending order of prevalence. 1 Non-asthmatic eosinophilic bronchitis (NAEB) should also be considered early in the evaluation. 1
Primary Differential Diagnosis:
- Upper Airway Cough Syndrome (UACS) - Most common cause, accounting for approximately 44% of chronic cough cases with normal chest radiographs 1
- Asthma - Second most common, may present without wheezing or abnormal lung sounds 1, 2
- Gastroesophageal Reflux Disease (GERD) - Third most common cause 1, 3
- Non-Asthmatic Eosinophilic Bronchitis (NAEB) - Frequent enough to warrant early consideration 1, 2
Critical Medication-Related Causes:
- ACE Inhibitor-Induced Cough - Must be excluded immediately; discontinue ACE inhibitor regardless of temporal relationship, as cough typically resolves within days to 2 weeks (median 26 days) 1, 2
- Beta-Blocker Exacerbation - May worsen underlying asthma 4
Other Important Considerations:
- Smoking-Related Chronic Bronchitis - 90-94% of smokers experience cough resolution within the first year of cessation 2
- Tuberculosis - Consider in patients from endemic areas or with systemic symptoms (fever, night sweats, weight loss) 1, 2
- Endobronchial Tumor - Rare with normal chest radiograph but must not be delayed if other causes are excluded 1
Initial Management Approach
Step 1: Immediate Actions
- Discontinue ACE inhibitors immediately if the patient is taking one, regardless of when the cough started 1, 2
- Counsel and assist with smoking cessation if applicable; most patients experience resolution within 4 weeks 1, 2
- Obtain chest radiograph to confirm normal findings and rule out structural abnormalities 2, 3
- Perform spirometry as part of basic evaluation, though utility is not clearly established 2
Step 2: Sequential Empiric Treatment
The algorithmic approach should start with treating the most common cause first, then add treatments sequentially if cough persists, as multiple causes frequently coexist. 1, 2
First-Line: Treat for UACS
- Use oral first-generation antihistamine/decongestant combination (not newer non-sedating antihistamines, which are ineffective) 2, 5
- Add topical nasal corticosteroid if prominent upper airway symptoms are present 2
- Trial duration: 4-6 weeks 2
Second-Line: Add Asthma Treatment
- Initiate inhaled bronchodilators and inhaled corticosteroids if spirometry shows reversible airflow obstruction 2, 5
- Consider bronchoprovocation challenge or empiric trial if spirometry is normal but asthma is suspected 2
- For refractory cases, add leukotriene receptor antagonist before escalating to systemic corticosteroids 5
Third-Line: Add GERD Treatment
- Initiate empiric treatment for patients with typical reflux symptoms before performing esophageal testing 2
- Continue for 4-6 weeks as part of additive therapy 2
Consider NAEB Early:
- Perform induced sputum test for eosinophils if available 2
- Use empiric inhaled corticosteroids if testing is unavailable 2
Step 3: Advanced Evaluation (If Cough Persists After 4-6 Weeks)
- Pursue high-resolution CT scan or bronchoscopic evaluation for uncommon causes 2, 6
- Consider referral to specialist cough clinic when diagnosis remains unclear 2
Critical Pitfalls to Avoid
- Do not rely on cough characteristics (timing, quality, sound) for diagnosis, as they have little diagnostic value 1, 2
- Do not treat only one cause - multiple factors often contribute simultaneously, requiring additive therapy rather than sequential replacement 1, 2
- Do not label as idiopathic until thorough assessment at a specialist clinic excludes uncommon causes 2
- Do not forget that cough is frequently multifactorial - it is not uncommon to find two or all three common diagnoses present, and cough will not resolve until all are effectively treated 1
- Do not use routine cough suppressants when cough clearance is important 2
Special Population Considerations
- Immunocompromised patients: Use the same initial algorithm but expand differential diagnosis based on immune defect type and severity 2, 5
- HIV patients with CD4+ <200 cells/μL: Suspect Pneumocystis pneumonia, tuberculosis, and opportunistic infections 2
- Endemic areas: Obtain sputum smears, cultures for acid-fast bacilli to evaluate for tuberculosis 2